Metagenomi Therapeutics Pre-Tax Profit Margin 2022-2026 | MGX
Metagenomi Therapeutics pre-tax profit margin from 2022 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Metagenomi Therapeutics Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $0.01B | $-0.09B | -664.29% |
| 2026-03-31 | $0.02B | $-0.09B | -373.91% |
| 2025-12-31 | $0.03B | $-0.09B | -338.46% |
| 2025-09-30 | $0.03B | $-0.09B | -284.38% |
| 2025-06-30 | $0.04B | $-0.09B | -260.00% |
| 2025-03-31 | $0.05B | $-0.08B | -182.61% |
| 2024-12-31 | $0.05B | $-0.08B | -158.49% |
| 2024-09-30 | $0.06B | $-0.08B | -138.18% |
| 2024-06-30 | $0.06B | $-0.07B | -134.55% |
| 2024-03-31 | $0.05B | $-0.07B | -156.52% |
| 2023-12-31 | $0.04B | $-0.06B | -138.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.043B | $0.025B |
| Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Bausch Health Cos (BHC) | Canada | $2.129B | 1.33 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |